|1.||Rock, Erin M: 3 articles (12/2015 - 08/2014)|
|2.||Parker, Linda A: 3 articles (12/2015 - 08/2014)|
|3.||Rock, E M: 3 articles (10/2013 - 03/2013)|
|4.||Parker, L A: 3 articles (10/2013 - 03/2013)|
|5.||Limebeer, Cheryl L: 2 articles (12/2015 - 08/2014)|
|6.||Takeda, Shuso: 2 articles (01/2014 - 11/2012)|
|7.||Watanabe, Kazuhito: 2 articles (01/2014 - 11/2012)|
|8.||Aramaki, Hironori: 2 articles (01/2014 - 11/2012)|
|9.||Downey, Rachel: 1 article (08/2014)|
|10.||Engeland, Kristin: 1 article (08/2014)|
08/01/2014 - "The effectiveness of cannabidiolic acid (CBDA) was compared with other potential treatments for anticipatory nausea (AN), using a rat model of contextually elicited conditioned gaping reactions. "
08/01/2014 - "A comparison of cannabidiolic acid with other treatments for anticipatory nausea using a rat model of contextually elicited conditioned gaping."
12/01/2015 - "Δ(9)-Tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) found in cannabis both reduce the distressing symptom of nausea, but their combined effects are not understood. "
12/01/2015 - "Effect of combined doses of Δ(9)-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea using rat (Sprague- Dawley) models of conditioned gaping."
10/01/2013 - "We then evaluated whether an ineffective low dose of cannabidiolic acid (CBDA, 0.1 μg/kg, Rock and Parker, 2013), the potent acidic precursor of cannabidiol (CBD, a non-psychoactive component of cannabis) could enhance the anti-nausea effects of an ineffective low dose of MCP. "
03/01/2013 - "To evaluate the ability of cannabidiolic acid (CBDA) to reduce nausea and vomiting and enhance 5-HT(1A) receptor activation in animal models. "
03/01/2013 - "Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation."
06/01/2015 - "Synergy between cannabidiol, cannabidiolic acid, and Δ⁹-tetrahydrocannabinol in the regulation of emesis in the Suncus murinus (house musk shrew)."
|3.||Breast Neoplasms (Breast Cancer)
11/15/2012 - "Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration."
01/01/2014 - "Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human breast cancer cells."
01/01/2014 - "To comprehensively analyze the effects of cannabidiolic acid (CBDA), a selective COX-2 inhibitor found in the fiber-type cannabis plant (Takeda et al., 2008), on COX-2 expression and the genes involved in metastasis, we performed a DNA microarray analysis of human breast cancer MDA-MB-231 cells, which are invasive breast cancer cells that express high levels of COX-2, treated with CBDA for 48 hr at 25 µM. "
|4.||Substance-Related Disorders (Drug Abuse)
03/01/2000 - "Ginsenoside increased drug accumulation and tumor antigen expression at 2.0-20.0 micrograms/mL. Some cannabinoid derivatives such as cannabinol, cannabispirol and cannabidiol increased drug accumulation, while cannabidiolic acid, delta-9-THC and tetrahydro-cannabidiolic acid reduced drug accumulation of the human mdr1-gene transfected mouse lymphoma cells. "
|4.||Cyclooxygenase 2 (Cyclooxygenase-2)
|5.||A-Form DNA (A-DNA)
|6.||5-HT1A Serotonin Receptor
|8.||Serotonin (5 Hydroxytryptamine)